Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated α-synuclein

Anne-Laure J Mougenot1, Anna Bencsik, Simon Nicot

  • 1Agence Nationale de Sécurité Sanitaire de l'alimentation, de l'environnement et du travail - ANSES, Lyon, France.

Insights

Prion diseases accelerated neurodegeneration in mice overexpressing human alpha-synuclein. H-type BSE triggered both prion disease and alpha-synuclein pathology, suggesting a link between misfolded proteins in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Protein misfolding diseases
  • Transmissible spongiform encephalopathies

Background:

  • Growing interest in misfolded protein interactions in neurodegeneration.
  • Transgenic (TgM83) mice overexpress human A53T α-synuclein.
  • Investigating prion strain effects on α-synucleinopathy.

Purpose of the Study:

  • To investigate the impact of prion strains on A53T α-synucleinopathy.
  • To determine if prion infection alters the course of α-synuclein accumulation.
  • To explore the interplay between prion diseases and synucleinopathies.

Main Methods:

  • Intracerebral inoculation of 3 prion strains (scrapie, C-BSE, H-BSE) into TgM83 mice.
  • Comparison with nontransgenic controls.
  • Histopathological and biochemical analysis of prion and α-synuclein pathology.

Main Results:

  • Scrapie and C-BSE shortened incubation periods but did not induce α-synuclein pathology before death.
  • H-BSE inoculation allowed α-synuclein alterations to develop.
  • Some H-BSE inoculated mice showed concomitant prion and α-synuclein pathology.

Conclusions:

  • Prion diseases can influence the progression of α-synucleinopathies.
  • H-BSE prion strain can trigger both prion disease and synucleinopathy in TgM83 mice.
  • Suggests a potential link between prion diseases and α-synuclein misfolding in neurodegeneration.

Related Concept Videos